Cargando…

Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials

Oral cancer (OC) is a devastating disease that takes the lives of lots of people globally every year. The current spectrum of treatment modalities does not meet the needs of the patients. The disease heterogeneity demands personalized medicine or targeted therapies. Therefore, there is an urgent nee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harsha, Choudhary, Banik, Kishore, Ang, Hui Li, Girisa, Sosmitha, Vikkurthi, Rajesh, Parama, Dey, Rana, Varsha, Shabnam, Bano, Khatoon, Elina, Kumar, Alan Prem, Kunnumakkara, Ajaikumar B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246494/ https://www.ncbi.nlm.nih.gov/pubmed/32384682 http://dx.doi.org/10.3390/ijms21093285

Ejemplares similares

Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer
por: Girisa, Sosmitha, et al.
Publicado: (2020)

Reiterating the Emergence of Noncoding RNAs as Regulators of the Critical Hallmarks of Gall Bladder Cancer
por: Rana, Varsha, et al.
Publicado: (2021)

Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer
por: Girisa, Sosmitha, et al.
Publicado: (2021)

TIPE2 Induced the Proliferation, Survival, and Migration of Lung Cancer Cells Through Modulation of Akt/mTOR/NF-κB Signaling Cascade
por: Bordoloi, Devivasha, et al.
Publicado: (2019)

Emerging roles of cardamonin, a multitargeted nutraceutical in the prevention and treatment of chronic diseases
por: Daimary, Uzini Devi, et al.
Publicado: (2020)

COVID-19, cytokines, inflammation, and spices: How are they related?
por: Kunnumakkara, Ajaikumar B., et al.
Publicado: (2021)

The promising potential of piperlongumine as an emerging therapeutics for cancer
por: Parama, Dey, et al.
Publicado: (2021)

Sorcin a Potential Molecular Target for Cancer Therapy
por: Shabnam, Bano, et al.
Publicado: (2018)

Resveratrol Modulates Chemosensitisation to 5-FU via β1-Integrin/HIF-1α Axis in CRC Tumor Microenvironment
por: Brockmueller, Aranka, et al.
Publicado: (2023)

Calebin A targets the HIF-1α/NF-κB pathway to suppress colorectal cancer cell migration
por: Brockmueller, Aranka, et al.
Publicado: (2023)

Potential of Zerumbone as an Anti-Cancer Agent
por: Girisa, Sosmitha, et al.
Publicado: (2019)

Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?
por: Hegde, Mangala, et al.
Publicado: (2023)

FBXW7 in Cancer: What Has Been Unraveled Thus Far?
por: Sailo, Bethsebie Lalduhsaki, et al.
Publicado: (2019)

Targeting Autophagy Using Long Non-Coding RNAs (LncRNAs): New Landscapes in the Arena of Cancer Therapeutics
por: Kumar, Aviral, et al.
Publicado: (2023)

Therapeutic Emergence of Rhein as a Potential Anticancer Drug: A Review of Its Molecular Targets and Anticancer Properties
por: Henamayee, Sahu, et al.
Publicado: (2020)

Unraveling the Potential Role of NEDD4-like E3 Ligases in Cancer
por: Jayaprakash, Sujitha, et al.
Publicado: (2022)

Repurposing FDA-approved drugs as FXR agonists: a structure based in silico pharmacological study
por: Jose, Sandra, et al.
Publicado: (2023)

An Investigation on the Therapeutic Potential of Butein, A Tretrahydroxychalcone Against Human Oral Squamous Cell Carcinoma
por: Bordoloi, Devivasha, et al.
Publicado: (2019)

Demystifying the Functional Role of Nuclear Receptors in Esophageal Cancer
por: Jayaprakash, Sujitha, et al.
Publicado: (2022)

Oroxylin A: A Promising Flavonoid for Prevention and Treatment of Chronic Diseases
por: Sajeev, Anjana, et al.
Publicado: (2022)

An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases
por: Roy, Nand Kishor, et al.
Publicado: (2019)

Chronic diseases, inflammation, and spices: how are they linked?
por: Kunnumakkara, Ajaikumar B., et al.
Publicado: (2018)

Targeting Nuclear Receptors in Lung Cancer—Novel Therapeutic Prospects
por: Gangwar, Shailendra Kumar, et al.
Publicado: (2022)

Googling the Guggul (Commiphora and Boswellia) for Prevention of Chronic Diseases
por: Kunnumakkara, Ajaikumar B., et al.
Publicado: (2018)

TIPE Family of Proteins and Its Implications in Different Chronic Diseases
por: Bordoloi, Devivasha, et al.
Publicado: (2018)

Targeting NF-κB Signaling by Calebin A, a Compound of Turmeric, in Multicellular Tumor Microenvironment: Potential Role of Apoptosis Induction in CRC Cells
por: Buhrmann, Constanze, et al.
Publicado: (2020)

Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer
por: Ranaware, Abhishek Manoj, et al.
Publicado: (2018)

Evidence That Tumor Microenvironment Initiates Epithelial-To-Mesenchymal Transition and Calebin A can Suppress it in Colorectal Cancer Cells
por: Buhrmann, Constanze, et al.
Publicado: (2021)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

The Paradox of Akt-mTOR Interactions
por: Vadlakonda, Lakshmipathi, et al.
Publicado: (2013)

NGAL is Downregulated in Oral Squamous Cell Carcinoma and Leads to Increased Survival, Proliferation, Migration and Chemoresistance
por: Monisha, Javadi, et al.
Publicado: (2018)

MicroRNAs as Modulators of Oral Tumorigenesis—A Focused Review
por: Rishabh, Kumar, et al.
Publicado: (2021)

Akt and mTOR in B Cell Activation and Differentiation
por: Limon, Jose J., et al.
Publicado: (2012)

Akt and mTOR mediate programmed necrosis in neurons
por: Liu, Q, et al.
Publicado: (2014)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

Inhibition of the AKT/mTOR pathway negatively regulates PTEN expression via miRNAs: Effect of Akt/mTOR inhibition on PTEN expression
por: Wan, Linyan, et al.
Publicado: (2022)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

PI3K/AKT/mTOR Pathway in Angiogenesis
por: Karar, Jayashree, et al.
Publicado: (2011)

mTOR signalling pathway - A root cause for idiopathic autism?
por: Ganesan, Harsha, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n0t4ve3k698gjl5g4u4j5rvslt